| Nereus Pharma Accepts $20 Million New Funding |
|
|
| Thursday, June 24, 2010 5:53:00 AM PDT | VentureDeal Staff |
San Diego, California -- Nereus Pharmaceuticals has secured $20 million in a new round of venture capital investment.
Nereus is developing a number of anticancer agents that are currently in mid-stage clinical trials.
HBM BioVentures led the round, which also included Advent International, Forward Ventures, Alta Partners, Gimv, Roche Venture Fund and Astellas Venture Management. |
|
|
 Email Page |  Print Page |
|
|
|
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
|
 |
|
|
|
 |